Key Metrics
CiteScore 

5.8
Eigenfactor 

0.005 - 0.01
Impact Factor 

< 5
SJR 

Q2Biochemistry

SNIP 

1.02
Recommended pre-submission checks
Powered by 

Topics Covered on Metabolic Brain Disease
Metabolic Brain Disease Journal Specifications
| Overview | |
| Publisher | SPRINGER/PLENUM PUBLISHERS |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1986 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Metabolic Brain Disease ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Metabolic Brain Disease
The protective role of melatonin on the brain in a rat model of Alzheimer's disease.
- 1 Jul 2026
- Metabolic brain disease
Neuroprotective effects of 2-(2-nitrophenyl)-1,3-thiazolidine-4-carboxylic acid in a rotenone-induced Parkinson's disease rat model: Modulation of oxidative stress, behavioral dysfunction, and iron accumulation.
- 1 Jul 2026
- Metabolic brain disease
Gestational deltamethrin exposure exacerbates post-traumatic epileptiform activity and social deficits, diminishing the therapeutic efficacy of curcumin in rats.
- 1 Jul 2026
- Metabolic brain disease
The interplay between gut microbiota and Alzheimer's disease: mechanistic insights from dysbiosis to disease modulation.
- 30 Jun 2026
- Metabolic brain disease
Gut-brain axis modulation by fecal microbiota transplantation improves dual-organ injury after cerebral ischemia-reperfusion via Caspase-8 dependent inhibition of necroptosis.
- 29 Jun 2026
- Metabolic brain disease
Bushen Huoxue Acupuncture alleviates alzheimer's disease progression via the E3 ubiquitin ligase SMURF2‑mediated ubiquitination of LAPTM5.
- 29 Jun 2026
- Metabolic brain disease
The protective role of melatonin on the brain in a rat model of Alzheimer's disease.
- 1 Jul 2026
- Metabolic brain disease
Neuroprotective effects of 2-(2-nitrophenyl)-1,3-thiazolidine-4-carboxylic acid in a rotenone-induced Parkinson's disease rat model: Modulation of oxidative stress, behavioral dysfunction, and iron accumulation.
- 1 Jul 2026
- Metabolic brain disease
Gestational deltamethrin exposure exacerbates post-traumatic epileptiform activity and social deficits, diminishing the therapeutic efficacy of curcumin in rats.
- 1 Jul 2026
- Metabolic brain disease
The interplay between gut microbiota and Alzheimer's disease: mechanistic insights from dysbiosis to disease modulation.
- 30 Jun 2026
- Metabolic brain disease
Gut-brain axis modulation by fecal microbiota transplantation improves dual-organ injury after cerebral ischemia-reperfusion via Caspase-8 dependent inhibition of necroptosis.
- 29 Jun 2026
- Metabolic brain disease
Bushen Huoxue Acupuncture alleviates alzheimer's disease progression via the E3 ubiquitin ligase SMURF2‑mediated ubiquitination of LAPTM5.
- 29 Jun 2026
- Metabolic brain disease